Model
Edge
Alnylam Pharmaceuticals, Inc.
0001298814
Filing type
4
Filing date
May 18, 2023
Updated
May 19, 2023 ยท 10:03 AM
Copy reference
Filing
4
Statement of Changes in Beneficial Ownership